Currently out of the existing stock ratings of Arthur He, 74 are a BUY (93.67%), 5 are a HOLD (6.33%).

Arthur He

Work Performance Price Targets & Ratings Chart

Analyst Arthur He, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 21.33% that have a potential upside of 22.06% achieved within 114 days.

Arthur He’s has documented 163 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VERA, Vera Therapeutics at 11-Aug-2026.

Wall Street Analyst Arthur He

Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for LVTX (LAVA THERAPEUTICS NV) at 8/4/2025. The price target of $1.5 was fulfilled within 1 day with a profit of $0.03 (2.04%) receiving and performance score of 20.41.

Average potential price target upside

SLDB Solid Biosciences LLC ADAG Adagene AUPH Aurinia Pharmaceuticals BCAB Bioatla  CALT Calliditas Therapeutics LVTX LAVA Therapeutics NV NKTR Nektar Therapeutics PRME Prime Medicine, Common Stock PSTX Poseida Therapeutics VERA Vera Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Mar-2024

$25

$15.71 (169.11%)

$20

Buy Since 12-Nov-2024

$12

$2.71 (29.17%)

$11

Buy Since 04-Dec-2025

$19

$9.71 (104.52%)

$16

Buy Since 13-Dec-2024

$17

$7.71 (82.99%)

$14

Show more analysts

Please expand the browser size to see the chart

Which stock is Arthur He is most bullish on?

Potential upside of $111.98 has been obtained for NKTR (NEKTAR THERAPEUTICS)

Which stock is Arthur He is most reserved on?

Potential downside of $4.91 has been obtained for PRME (PRIME MEDICINE, COMMON STOCK)

What Year was the first public recommendation made by Arthur He?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?